Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease

Patients with chronic kidney disease (CKD) have an increased risk of fracture. Raloxifene is a mild anti-resorptive agent that reduces fracture risk in the general population. Here we assessed the impact of raloxifene on the skeletal properties of animals with progressive CKD. Male Cy/+ rats that de...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, Christopher L., Creecy, Amy, Granke, Mathilde, Nyman, Jeffry S., Tian, Nannan, Hammond, Max A., Wallace, Joseph M., Brown, Drew M., Chen, Neal, Moe, Sharon M., Allen, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840093/
https://www.ncbi.nlm.nih.gov/pubmed/26489025
http://dx.doi.org/10.1038/ki.2015.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840093/
https://www.ncbi.nlm.nih.gov/pubmed/26489025
http://dx.doi.org/10.1038/ki.2015.315

Ejemplares similares